Joensuu, H. (2014) “Outcome of patients with HER2-positive breast cancer treated with or without adjuvant trastuzumab in the Finland Capecitabine Trial (FinXX)”, Acta Oncologica, 53(2), pp. 186–194. doi: 10.3109/0284186X.2013.820840.